KTH Ventures invests in Samplimy Medical in minority stake deal

• KTH Holding AB invested in Samplimy Medical, a KTH spin-off developing microsampling devices for painless, self-collected blood and dermal fluid samples.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KTH Holding AB published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.